An Axendia, Inc. webinar brought to you by Tulip featuring AstraZeneca
Manufacturers are now empowered to adopt a risk-based assurance approach and focus on what’s really important: patient safety and product quality. Despite this guidance, many manufacturers are struggling to shift their old ways.
Top Takeaways:
Understand the basic objectives of systems validation and how to achieve it with current digital tools focusing on the intended use and risk to patient safety, product quality, and regulatory compliance
Understand how to move beyond a traditional validation approach and its reliance on non-value-added documentation to unblock your digital transformation
Explore real-world success stories on how to use the CSA approach to accelerate digital transformation
Featuring:
-
Daniel R. Matlis
President & Founder, Axendia, Inc
-
Michelle Vuolo
Head of Quality, Tulip
-
Bob Buhlmann
Head of Quality Digital & Computer Strategy, AstraZeneca